Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Overall I like this deal for Pfizer and I imagine they will continue to invest heavily in building out the clinical programs for Metseras portfolio beyond obesity, both to help stem revenue loss from LOEs of ELIQUIS and eventually leverage that commercial footprint towards its budding obesity portfolio.
Patient safety and comfort are paramount at all our locations
Both help control appetite and support weight loss, but they act on the body in slightly different ways
Starting dose and long-term protocol planning The starting dose is the first chapter, not the whole story
US$ 21.27
US$ 28.49
US$ 21.66
US$ 24.88
